Early cancer detection can significantly improve treatment outcomes and survival rates. By incorporating advanced screening method like Galleri, LifeGenix offers a proactive approach to health that provides numerous benefits:

• Early Detection Saves Lives: Detecting cancer at an early stage allows for more treatment options, less invasive therapies, and higher survival rates. Galleri’s high sensitivity for multiple cancer types, enable detection before symptoms appear.
• Broader Cancer Detection: Traditional screenings often focus on a few common cancers (e.g., breast, colon, lung). The Galleri test screens for over 50 types of cancer, many of which lack routine screening methods. This significantly expands the scope of cancers that can be detected early.
• Minimized False Positives:  Galleri uses advanced technology to reduce false positives. Galleri, for example, boasts a 99.5% specificity rate, minimizing unnecessary diagnostic procedures. This ensures a more reliable screening process and reduces stress for patients.
• Informed Treatment Pathways: With the Galleri test, healthcare providers receive information on the cancer signal origin with 88% accuracy, helping guide next steps for diagnostic testing and treatment. This precision enables faster, more targeted follow-up actions.
• Non-Invasive and Convenient: The test is simple, non-invasive blood tests, making them convenient and accessible. There’s no need for complex procedures or significant downtime, allowing individuals to maintain their routine while staying proactive about their health.
• Screening for High-Risk Individuals: Galleri’s test is particularly beneficial for those with a family history of cancer or other risk factors.